BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23893316)

  • 1. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
    Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
    Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
    Andaloussi SE; Lehto T; Mäger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Said Hassane F; Guterstam P; Suhorutšenko J; Moreno PM; Oskolkov N; Hälldin J; Tedebark U; Metspalu A; Lebleu B; Lehtiö J; Smith CI; Langel U
    Nucleic Acids Res; 2011 May; 39(9):3972-87. PubMed ID: 21245043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
    Toriyabe N; Hayashi Y; Harashima H
    Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between a cell penetrating peptide and a pH-sensitive cationic lipid in efficient gene delivery based on double-coated nanoparticles.
    Khalil IA; Kimura S; Sato Y; Harashima H
    J Control Release; 2018 Apr; 275():107-116. PubMed ID: 29452131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PepFect6 Mediated SiRNA Delivery into Organotypic Cultures.
    Dash-Wagh S; Langel Ü; Ulfendahl M
    Methods Mol Biol; 2016; 1364():27-35. PubMed ID: 26472439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
    Wan Y; Moyle PM; Gn PZ; Toth I
    Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
    Golan M; Feinshtein V; David A
    Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.
    El-Sayed A; Masuda T; Akita H; Harashima H
    J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
    Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
    Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of siRNA Using Lipid Nanoparticles Modified with Cell Penetrating Peptide.
    Li Y; Lee RJ; Yu K; Bi Y; Qi Y; Sun Y; Li Y; Xie J; Teng L
    ACS Appl Mater Interfaces; 2016 Oct; 8(40):26613-26621. PubMed ID: 27617513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA-loaded poly(histidine-arginine)
    Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
    Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape.
    El-Sayed A; Khalil IA; Kogure K; Futaki S; Harashima H
    J Biol Chem; 2008 Aug; 283(34):23450-61. PubMed ID: 18550548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment.
    Ruan W; Zhai Y; Yu K; Wu C; Xu Y
    Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6.
    Dash-Wagh S; Jacob S; Lindberg S; Fridberger A; Langel U; Ulfendahl M
    Mol Ther Nucleic Acids; 2012 Dec; 1(12):e61. PubMed ID: 23232329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
    Kogure K
    Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.